BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28251449)

  • 1. A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses.
    Wang X; Ai L; Xu Q; Wu C; Chen Z; Su D; Jiang X; Fan Z
    Inflammation; 2017 Jun; 40(3):840-848. PubMed ID: 28251449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
    Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
    Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockout of the Cannabinoid Receptor 2 Gene Promotes Inflammation and Hepatic Stellate Cell Activation by Promoting A20/Nuclear Factor-κB (NF-κB) Expression in Mice with Carbon Tetrachloride-Induced Liver Fibrosis.
    Long C; Xie N; Shu Y; Wu Y; He P; Zhou Y; Xiang Y; Gu J; Yang L; Wang Y
    Med Sci Monit; 2021 Aug; 27():e931236. PubMed ID: 34413280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saikosaponin A of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation.
    Wang X; Wang Q; Burczynski FJ; Kong W; Gong Y
    Phytomedicine; 2013 Nov; 20(14):1330-5. PubMed ID: 23969230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD.
    Vespasiani-Gentilucci U; Carotti S; Perrone G; Mazzarelli C; Galati G; Onetti-Muda A; Picardi A; Morini S
    Liver Int; 2015 Feb; 35(2):569-81. PubMed ID: 24649857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells.
    Wang Y; Song J; Bian H; Bo J; Lv S; Pan W; Lv X
    Mol Cell Biochem; 2019 Oct; 460(1-2):205-215. PubMed ID: 31270645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression.
    Zhang YQ; Wan LY; He XM; Ni YR; Wang C; Liu CB; Wu JF
    DNA Cell Biol; 2017 Jul; 36(7):603-610. PubMed ID: 28467108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
    Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
    Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
    Li BH; He FP; Yang X; Chen YW; Fan JG
    Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASH.
    Sharma L; Gupta D; Abdullah ST
    Toxicol Lett; 2019 Apr; 304():21-29. PubMed ID: 30625377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis.
    Wang W; Zhao C; Zhou J; Zhen Z; Wang Y; Shen C
    PLoS One; 2013; 8(10):e76538. PubMed ID: 24098525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of CCN5 overexpression on the expression of alpha-SMA and collagen I in hepatic stellate cells and its mechanism].
    Zhang CY; Xie X; Gao DS; Zhang CX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):411-5. PubMed ID: 24386815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease.
    Li G; Zhang J; Jiang Q; Liu B; Xu K
    Life Sci; 2020 Aug; 254():117795. PubMed ID: 32417373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.
    Yang Y; Kim B; Park YK; Koo SI; Lee JY
    Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
    Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L
    Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adiponectin inhibits the activation of hepatic stellate cells induced by TGFb1 via up-regulating the expression of eNOS].
    Wang W; Zhao CY; Wang YD; He X; Shen C; Cao W; Zhou JY; Zhen Z
    Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):917-22. PubMed ID: 22525505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.